- Research works
- 1 fractional, all time
- Citations
- 6 8.6 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 31% world 28%
Not ranked overall: Cliris (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Cliris (Switzerland) publish most on?
By volume in 2022–2025: Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Treatment and Management and Hyperglycemia and glycemic control in critically ill and hospitalized patients.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 0 works
- 2 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
- 3 Hyperglycemia and glycemic control in critically ill and hospitalized patients Endocrinology, Diabetes and Metabolism 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
Other research institutions in Yverdon-les-Bains
- Y-Parc (Switzerland)
- Haute école d'ingénierie et de gestion du canton de Vaud, HES-SO Haute Ecole Spécialisée de Suisse Occidentale
- SOLIDpower (Switzerland)
- Symbios Orthopédie (Switzerland)
- Dentsply Sirona (Switzerland)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.